Select language:

Clinical trials of Sputnik Light have been completed

 / Главная / Russkiy Mir Foundation / News / Clinical trials of Sputnik Light have been completed

Clinical trials of Sputnik Light have been completed


22.03.2021

Photo credit: Tumisu / pixabay.com

No later than May, the Sputnik Light vaccine must enter civilian circulation, TASS reports. Alexey Repik, who heads the R-Pharm company, promised that this would happen this spring. He said this during a meeting on vaccination against coronavirus, which was chaired by Russian President Vladimir Putin on Monday, March 22.

Health Minister Mikhail Murashko previously reported that clinical trials of the drug had come to an end. According to him, all documents for registration are ready.

The difference between the new modification and Sputnik V is that vaccination participants will be given one injection. Sputnik Light is planned to be used for inoculation of young people from 18 to 30 years old, in whom the necessary immune response should follow after just one replication.

Russkiy Mir

News by subject

Publications

Marco Maggi: ”Russian to the Bone" 20.01.2024
Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.